Synonyms: amiloride HCl | Midamor®
amiloride is an approved drug (FDA (1981))
Compound class:
Synthetic organic
Comment: Amiloride is a loop diuretic drug.
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖![]() View more information in the IUPHAR Pharmacology Education Project: amiloride |
|
No information available. |
Summary of Clinical Use ![]() |
Used in the treatment of congestive heart failure or hypertension as an adjunctive treatment to thiazide diuretics or other kaliuretic-diuretic agents. Amiloride, along with riluzole and fluoxetine are repurposing candidates as potential therapeutics for secondary progressive multiple sclerosis (SPMS or late MS), having already been shown to provide neuroprotective benefit [1,3,5-6]. A Phase 2 clinical trial (NCT01910259, MS-SMART trial) is recruiting patients (April 2015). |
Clinical Trials | |||||
Clinical Trial ID | Title | Type | Source | Comment | References |
NCT01910259 | MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial | Phase 2 Interventional | University College, London |
External links ![]() |
For extended ADME data see the following: Electronic Medicines Compendium (eMC) Drugs.com |